Digital marketing for private clinics and aesthetic practices

Botulinum toxin is a prescription-only medicine. UK medicines law prohibits advertising prescription-only medicines to the public, and the CAP Code carries the same prohibition, so no public-facing marketing may promote it. The Advertising Standards Authority applies that broadly. Brand names are out. So are the euphemisms the industry invented to get around it — wrinkle-relaxing injections, anti-wrinkle treatment, and the various nicknames — because the audience understands exactly which medicine is meant. Hashtags count. Before-and-after images that make clear a prescription-only treatment was administered count as implied promotion of the medicine. What remains permitted is genuinely useful: information about how skin and facial structure change with age, what a consultation involves, who assesses you, how a prescriber makes a decision, and what happens at a first appointment. Promotion to healthcare professionals is a separate matter and remains allowed. So the treatment that drives most of the sector's revenue is one your website cannot sell, and the strategy has to be built on that fact rather than around it.

That changes the shape of the funnel. Instead of ranking a treatment page and driving bookings, the clinic markets the consultation, the practitioner and the clinic itself, and the clinical conversation happens after the patient makes contact. Practically, that means the assets you can build are practitioner credentials and prescribing status, the assessment process, aftercare and complication management, skin health content, and the treatments that are not prescription-only — dermal fillers are medical devices rather than medicines, and skin treatments, laser and peels sit outside the medicines prohibition, although the CAP Code's separate rules on cosmetic interventions still apply to all of them. Age matters too: administering botulinum toxin or cosmetic fillers to under-18s for cosmetic purposes has been an offence in England since 2021, and arranging or booking it is caught as well, so audience targeting and any booking flow need to reflect that rather than assume it.

Trust signals in this sector are frequently claimed loosely, which is a risk in itself. Care Quality Commission registration is required where a clinic carries on a regulated activity, but a great many purely cosmetic treatments fall outside that scope, so a clinic that states it is CQC registered when it is not is making a false claim about regulation on its own homepage. A separate licensing scheme for non-surgical cosmetic procedures in England has been consulted on and the government has published its response, but it is not yet in force — treat anything you read about mandatory licences as pending, not current. What is unambiguous is that a prescriber must assess the patient before prescribing, which is exactly why the consultation, not the treatment, is the thing worth marketing. The economics support that anyway: toxin patients typically return every few months, so the value of a first appointment is a course of treatments over years, and the acquisition cost should be judged against that rather than against one visit.